Yang Jing1,2,
Wen Zhang2,
Hui Liu2,
Yujuan Wang2,
Guoxi Zheng1
For correspondence:- Guoxi Zheng Email: GideonMarquezffo@yahoo.com Tel:+862987679000
Accepted: 22 July 2019 Published: 28 August 2019
Citation: Jing Y, Zhang W, Liu H, Wang Y, Zheng G. Arylsulfonyl indoline-enzamide exhibits inhibitory effect on nasopharyngeal carcinoma. Trop J Pharm Res 2019; 18(8):1643-1649 doi: 10.4314/tjpr.v18i8.11
© 2019 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..
Archives
News Updates